An interventional study of Facilitated Transition to Primary Care in Hypertension, Diabetes and Postpartum, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-13.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Hypertension by Massachusetts General Hospital — 4 open to participants now, 4 under way, none of them phase 3. Hypertension · Massachusetts General Hospital.
Among the 24 studies in Hypertension by Massachusetts General Hospital, this one is the 2nd largest by planned enrollment of the 21 interventional ones that give a count, is one of 3 that started in 2025, is one of 18 with no phase, and was the 21st registered.
6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.
Browse Hypertension studies →4 of the 24 studies in Hypertension by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:
Massachusetts General Hospital · Sites in United States
Ages 18–65 · Women only
Massachusetts General Hospital · Sites in United States
Ages 18+ · Women only
Massachusetts General Hospital · Sites in United States
Ages 35+
By country, each count listing its studies:
Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,320 is above the median of 100 across 4,585 interventional studies indexed under Hypertension.
Median enrollment 80 across the 21 interventional studies, 539 across the 3 observational. Of the 18 that completed or were terminated, 4 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
Massachusetts General Hospital is the lead sponsor of 2,591 studies on the registry; 445 are open to participants now.
Of its 224 completed or terminated interventional studies of FDA-regulated products, 168 (75%) have results posted.
1 of the studies in Hypertension by Massachusetts General Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06557005Massachusetts General HospitalFacilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions | 2027-05-23 |
Add it to your calendar (.ics) → With an account.
Among the 24 studies in Hypertension by Massachusetts General Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The lack of postpartum primary care coordination is a missed opportunity to increase primary care engagement and manage chronic conditions early in life, especially for the >30% of pregnant people who have or are at risk for these conditions. This study aims to increase postpartum primary care engagement, quality, and experience by strengthening postpartum transitions to primary care using a behavioral economics-informed, multi-component intervention integrated into usual inpatient postpartum care. Using a randomized controlled trial and repeated outcome assessments through administrative and survey data, this study will generate rigorous, actionable evidence to ensure primary care coordination becomes standard postpartum care practice, potentially catalyzing sustained primary care engagement throughout life.
Over 30% of pregnant people have at least one chronic medical condition, and 20% have certain prenatal conditions (e.g., pregnancy-related hypertension, gestational diabetes) that increase the risk of chronic disease later in life. While patients with these conditions are typically highly engaged in prenatal care, they encounter a "postpartum cliff" in health system support after delivery; many receive no postpartum primary care at all despite having ongoing medical needs. At a time of increased stress, sleep deprivation, and competing demands, they must navigate administrative burdens in accessing primary care, often without scheduling assistance or any formal handoff between their obstetric and primary care clinician (PCP). These burdens may lead to avoided or delayed postpartum primary care, exacerbating health inequities that existed prenatally even for those fortunate enough to have a PCP. Given the many benefits of primary care, this lack of obstetric-to-primary care coordination represents a missed opportunity to increase primary care engagement and manage chronic conditions earlier in life. The primary objective is to increase postpartum primary care engagement, quality, and experience by strengthening obstetric-to-primary care coordination using a behavioral economics-informed intervention. The intervention, integrated into routine inpatient postpartum care, includes default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient. Using a robust randomized controlled trial of 1,320 participants that is built off of the team's pilot study, the proposed study will: (Aim 1) measure the intervention's impact on postpartum primary care visit completion, sustained engagement, and disparities in these outcomes; (Aim 2) measure the intervention's impact on high-value primary care service use; and (Aim 3) measure the intervention's impact on patient experience. The study will generate rigorous, actionable evidence to ensure primary care coordination becomes standard postpartum care practice and will provide insight into postpartum patients' health care experiences. By targeting a vulnerable population at a time of great need and opportunity, postpartum-to-primary care coordination has the potential to catalyze sustained primary care engagement throughout life and improve long-term health.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Has one or more of the following conditions listed in the "Problem List," "Medical History," or clinical notes during prenatal, intrapartum, or postpartum encounters in the EHR (or in the case of , the patient's anthropometric measurements):
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Routine postpartum care
The intervention is integrated into routine inpatient postpartum care and includes the following components: default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.
Other: Facilitated Transition to Primary Care
The intervention includes default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.
Completion of a primary care visit
Observation of a visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).
Time frame: 155 days after date of delivery
Receipt of condition-specific recommended health screening and counseling by a primary care practitioner
For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record. For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record. "
Time frame: 155 days after date of delivery
Self-report of having a known, reliable primary care practitioner
The outcome is the Self-report of having a known, reliable primary care practitioner (doctor, nurse practitioner, or physician's assistant).
Time frame: 155 days after date of delivery
Self-report of mental health
Edinburgh Perinatal Depression Scale will be administered and the total EPDS score compared.
Time frame: 155 days after date of delivery
Completion of an annual exam with a primary care practitioner
Observation of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).
Time frame: 155 days after date of delivery
Self-report of completion of a primary care visit
Self-report of a visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology) for any reason.
Time frame: 155 days after date of delivery
Self-report of an annual exam with a primary care practitioner
Self-report of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).
Time frame: 155 days after date of delivery
Completion of a primary care visit
Observation of a visit with a primary care practitioner for any reason.
Time frame: 365 days after date of delivery
Self-report of completion of a primary care visit
Self-report of a visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology) for any reason.
Time frame: 365 days after date of delivery
Completion of an annual exam with a primary care practitioner
Observation of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).
Time frame: 365 days after date of delivery
Self-report of an annual exam with a primary care practitioner
Self-report of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).
Time frame: 365 days after date of delivery
Repeated primary care practitioner engagement
Observation of two or more primary care practitioner visits for any reason.
Time frame: 365 days after date of delivery
Self-report of repeated primary care practitioner engagement
Self-report of two or more primary care practitioner visits for any reason.
Time frame: 365 days after date of delivery
Extent of primary care practitioner engagement
Number of primary care practitioner visits for any reason.
Time frame: 365 days after date of delivery
Self-report of extent of primary care practitioner engagement
Self-report of the number of primary care practitioner visits for any reason.
Time frame: 365 days after date of delivery
Completion of a primary care visit
Observation of a visit with a primary care practitioner for any reason.
Time frame: 548 days after date of delivery
Completion of an annual exam with a primary care practitioner
Observation of an annual exam or health care maintenance visit with a primary care practitioner.
Time frame: 548 days after date of delivery
Repeated primary care practitioner engagement
Observation of two or more primary care practitioner visits for any reason.
Time frame: 548 days after date of delivery
Extent of primary care practitioner engagement
Number of primary care practitioner visits for any reason.
Time frame: 548 days after date of delivery
Self-report of receipt of condition-specific recommended health screening and counseling by a primary care practitioner
For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as reported by the participant. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) as reported by the participant. For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as reported by the participant.
Time frame: 155 days after date of delivery
Receipt of recommended screening and counseling for chronic condition by primary care practitioner
For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record.
Time frame: 155 days after date of delivery
Receipt of recommended screening for gestational condition by primary care practitioner
For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record."
Time frame: 155 days after date of delivery
Receipt of recommended screening and counseling for chronic condition by primary care practitioner
For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record.
Time frame: 365 days after date of delivery
Receipt of recommended screening for gestational condition by primary care practitioner
For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record.
Time frame: 365 days after date of delivery
Receipt of recommended screening and counseling for chronic condition by primary care practitioner
For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record.
Time frame: 548 days after date of delivery
Receipt of recommended screening for gestational condition by primary care practitioner
For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record.
Time frame: 548 days after date of delivery
Self-report of receipt of recommended screening and counseling for chronic condition by primary care practitioner
For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as reported by the participant.
Time frame: 365 days after date of delivery
Self-report of receipt of recommended screening for gestational condition by primary care practitioner
For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as reported by the participant. For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) as reported by the participant. "
Time frame: 365 days after date of delivery
Self-report of having a known, reliable primary care practitioner
Participant report of having a known, reliable primary care practitioner (doctor, nurse practitioner, or physician's assistant).
Time frame: 365 days after date of delivery
Urgent or emergent care use
Emergency department or urgent care visit for any reason as documented in the electronic health record.
Time frame: 155 days after date of delivery
Self-report of urgent or emergent care use
Emergency department or urgent care visit for any reason as documented as reported by the participant.
Time frame: 155 days after date of delivery
Urgent or emergent care use
Emergency department or urgent care visit for any reason as documented in the electronic health record.
Time frame: 365 days after date of delivery
Self-report of urgent or emergent care use
Emergency department or urgent care visit for any reason as reported by the participant.
Time frame: 365 days after date of delivery
Self-report of mental health
Edinburgh Perinatal Depression Scale score as reported by the participant.
Time frame: 365 days after date of delivery
Urgent or emergent care use
Emergency department or urgent care visit for any reason as documented in the electronic health record.
Time frame: 584 days after date of delivery
Interpregnancy interval
Defined as the time (in days) from date of delivery until subsequent date of conception.
Time frame: 365 days after date of delivery
Interpregnancy interval
Defined as the time (in days) from date of delivery until subsequent date of conception.
Time frame: 584 days after date of delivery
Prescription or documentation of medication use for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder
Observation of a prescription for or provider documentation noting the use of a medication for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder in the electronic health record.
Time frame: 155 days
Prescription or documentation of medication use for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder
Observation of a prescription for or provider documentation noting the use of a medication for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder in the electronic health record.
Time frame: 365 days
Prescription or documentation of medication use for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder
Observation of a prescription for or provider documentation noting the use of a medication for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder in the electronic health record.
Time frame: 584 days
Contraception use
The use of any form of contraception as documented in the electronic health record
Time frame: 155 days
Contraception use
The use of any form of contraception as documented in the electronic health record
Time frame: 365 days
Contraception use
The use of any form of contraception as documented in the electronic health record
Time frame: 584 days
Self-report of contraception
Self-report of using contraception or discussing family planning/contraception
Time frame: 155 days
Self-report of contraception
Self-report of using contraception or discussing family planning/contraception
Time frame: 365 days
Plan to share: Yes — Data sets generated for this analysis will be preserved and shared publicly after planned primary and secondary analyses are completed by the research team or at the end of the award, whichever occurs last. Data will be preserved for at least 5 years after public posting to ensure outside investigators can access and use this information for related research. Study metadata, code, and a deidentified data set that includes all collected trial data will be publicly available, without restricted access, on the Harvard Dataverse Repository.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code
Time frame: Data and materials will be available after planned primary and secondary analyses are completed by the research team or at the end of the award, whichever occurs last (expected 08/2029). Data will be available and accessible for at least 5 years after posting.
Access criteria: Study metadata, code, and a deidentified data set that includes all collected trial data will be publicly available, without restricted access, on the Harvard Dataverse Repository
Data sharing details ↗ · dataverse.harvard.edu
No publications or documents are linked to this record.
Started May 2025 (actual). Primary completion is estimated for May 2027, 24 months after the start.
Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 24 months is close to that.
Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital →